New Sars commissioner appointed - EWN

New Sars commissioner appointed  EWN

Edward Kieswetter's appointment to the Revenue *Service* is effective from 1 May this year.



Comments

Post a Comment

Popular posts from this blog

“63 Signs You May Have Long COVID | Eat This Not That - Eat This, Not That” plus 3 more

Image
“63 Signs You May Have Long COVID | Eat This Not That - Eat This, Not That” plus 3 more 63 Signs You May Have Long COVID | Eat This Not That - Eat This, Not That Why the Maternal Medication List Matters: Neonatal Toxicity From Combined Serotonergic Exposures - American Academy of Pediatrics An afternoon nap could improve your cognitive abilities, study says - Arizona Daily Star Sharp pain when breathing in: Chest, ribs, causes, and more - Medical News Today 63 Signs You May Have Long COVID | Eat This Not That - Eat This, Not That Posted: 16 Jan 2021 12:00 AM PST A few months into the COVID-19 pandemic, health experts noticed that some people who battled the virus—mild, moderate, and severe infections included—weren't recovering from it. In fact, they reported lingering symptoms that increased in severity after their initial infection had cleared. For long haulers, "it is certainly clear that for around 1...
Read more

“Stem cells: A possible treatment for severe respiratory failure, a COVID-19 complication - Mirage News” plus 1 more

Image
“Stem cells: A possible treatment for severe respiratory failure, a COVID-19 complication - Mirage News” plus 1 more Stem cells: A possible treatment for severe respiratory failure, a COVID-19 complication - Mirage News Posted: 21 Dec 2020 08:08 AM PST UC Davis Health scientists have joined a landmark multicenter clinical trial to test whether a type of stem cell may help reduce inflammation in the lungs of patients with acute respiratory distress syndrome (ARDS), a life-threatening lung injury. They will study the potential role these cells play in reducing the severity of ARDS in patients with and without COVID-19. New study to test stem cells' ability to treat patients with acute lung injury The phase III trial, sponsored by the U.S. Department of Defense and the California Institute of Regenerative Medicine (CIRM), is led by Michael Matthay , a professor of pulmonology at UCSF. At UC Davis Health, it is co-manage...
Read more